Abstract:Liver biopsy is considered to be the gold standard for analyzing chronic hepatitis and fibrosis; however, it is an invasive and expensive approach, which is also difficult to standardize. Medical imaging techniques such as ultrasonography, computed tomography (CT), and magnetic resonance imaging are non-invasive and helpful methods to interpret liver texture, and may be good alternatives to needle biopsy. Recently, instead of visual inspection of these images, computer-aided image analysis based approaches have become more popular. In this study, a non-invasive, low-cost and relatively accurate method was developed to determine liver fibrosis stage by analyzing some texture features of liver CT images. In this approach, some suitable regions of interests were selected on CT images and a comprehensive set of texture features were obtained from these regions using different methods, such as Gray Level Co-occurrence matrix (GLCM), Laws’ method, Discrete Wavelet Transform (DWT), and Gabor filters. Afterwards, sequential floating forward selection and exhaustive search methods were used in various combinations for the selection of most discriminating features. Finally, those selected texture features were classified using two methods, namely, Support Vector Machines (SVM) and k-nearest neighbors (k-NN). The mean classification accuracy in pairwise group comparisons was approximately 95% for both classification methods using only 5 features. Also, performance of our approach in classifying liver fibrosis stage of subjects in the test set into 7 possible stages was investigated. In this case, both SVM and k-NN methods have returned relatively low classification accuracies. Our pairwise group classification results showed that DWT, Gabor, GLCM, and Laws’ texture features were more successful than the others; as such features extracted from these methods were used in the feature fusion process. Fusing features from these better performing families further improved the classification performance. The results show that our approach can be used as a decision support system in especially pairwise fibrosis stage comparisons.

Development of a classification method for mild liver fibrosis using non-contrast CT image

Noninvasive assessment of liver fibrosis by dual-layer spectral detector CT

Development and validation of a novel score for fibrosis staging in patients with chronic hepatitis B.

Recent advances in molecular magnetic resonance imaging of liver fibrosis.

Non-invasive Liver Fibrosis Screening on CT Images using Radiomics

Assessment of Liver Fibrosis in the Early Stages with Perfusion CT.

Use of Texture Analysis on Noncontrast MRI in Classification of Early Stage of Liver Fibrosis

Noninvasive Assessment of Liver Fibrosis: Current and Future Clinical and Molecular Perspectives

Stratification of Patients With Liver Fibrosis Using Dual-Energy CT

Assessment of Liver Fibrosis by Variable Flip Angle T-1 Mapping at 3.0T

Multiparametric CT for Noninvasive Staging of Hepatitis C Virus–Related Liver Fibrosis: Correlation With the Histopathologic Fibrosis Score

Noninvasive staging of liver fibrosis: review of current quantitative CT and MRI-based techniques

Point‐of‐care detection of fibrosis in liver transplant surgery using near‐infrared spectroscopy and machine learning

Liver fibrosis staging using CT image texture analysis and soft computing

Current Imaging Techniques for Noninvasive Staging of Hepatic Fibrosis

Prediction of Early-stage Liver Fibrosis Using FDG-PET/CT

[Computer-Aided Assessment of Liver Fibrosis Progression in Patients with Chronic Hepatitis B: an Exploratory Research].

Advancements of non‐invasive imaging technologies for the diagnosis and staging of liver fibrosis: Present and future

Multidetector Computed Tomography for Retrospective, Noninvasive Staging of Liver Fibrosis

Diagnosis of Fibrosis Using Blood Markers and Logistic Regression in Southeast Asian Patients With Non-alcoholic Fatty Liver Disease

A Novel Model for Detecting Advanced Fibrosis in Patients with Nonalcoholic Fatty Liver Disease.